The negative impact of BCL2/CD200 co-expression on OS was also maintained in multivariate analysis, along with known prognostic factors such as advanced age, high WBC count (a surrogate of leukemic burden), secondary AML, and CD34 positivity. Here, BCL2 is linked to acute myeloid leukemia.